Chimeric antigen receptor compositions
AssigneeCity of Hope
InventorsJohn C. Williams, Christine Brown
Life of this patent
Estimating the term…
Abstract
Provided herein are compositions, which exhibit diagnostic capabilities and allow to rapidly add functionality to adoptive immunotherapy. The compositions include isolated nucleic acids encoding proteins including antibody regions capable of binding compounds including a peptidyl moiety (e.g., a meditope). The recombinant proteins provided herein are useful, inter alia, for a broad variety of therapeutic and diagnostic purposes. For example, the recombinant proteins provided herein including embodiments thereof may be used as non-invasive means to characterize chimeric antigen receptor (CAR) T cells before and/or during treatment of diseases (e.g., cancer).
Claims17
An isolated nucleic acid encoding a protein comprising:
- (i) a first portion comprising an antibody heavy chain variable domain and an antibody heavy chain constant domain;
- (ii) a second portion comprising an antibody light chain variable domain and an antibody light chain constant domain;
- (iii) a self-cleaving peptidyl sequence between said first portion and said second portion;
- and
- (iv) a CD3 ξ intracellular T-cell signaling domain;
- wherein said first portion further comprises a transmembrane domain;
- and
- wherein the nucleic acid sequence encoding said second portion is 3′ to the nucleic acid sequence encoding said first portion.
Dependencies are inferred from the claim text.